Summary of selected cytotoxicity and bio-imaging for various nanoparticles, 2003-2012.
1. Introduction
Fundamental properties of nanomaterials are strong function of their size and shapes. Surfactants are also equally important, since not only it stabilizes the nanoparticles but also makes nanoparticles compatible for various biomedical applications. The different size and shapes of the nanoparticles certainly have an influence and important place in clinical applications.
Earlier, we studied [1] the I-V response of electron transport within the plain and normal to the film surface of gold nanotriangles formed using the crude lemongrass extract. The I-V plot was fairly linear for the out-of-plane measurement while considerably higher across the film surface (681 kΩ) than within the plane of the film (32 kΩ). This could be due to the field-enhancement effects (FEE) near the sharp vertices of the nanotriangles considerably higher when the electric field was applied parallel to the film surface than when applied normal to the film surface. The FEE near sharp vertices of single crystalline triangular gold nanoprisms (Figure 1A) would be more as compare to truncated (1B) triangular gold nanoprisms. Costa and Dmitriev observed the better field confinement and enhancement in the plane
Ankamwar
Gold nanotriangles have potential applications in hyperthermia of tumors. Triangular gold nanoprisms functionalized by suitable antibody can be delivered by intra-venous injection and preferentially associate with cancerous cells as an effect of strong affection of antibody for corresponding antigens of cancerous cells.
We can selectively kill cancerous cells by focusing IR radiation using laser (850-1100 nm) to heat up cancerous cells associated with functionalized TGNs, thus hyperthermia of tumors could be exploited for practical purposes. Ankamwar
The spherical (Figure 2 A) biogenic gold nanoparticles synthesized using
Intrinsic properties such as Surface Plasmon Resonance (SPR) of Ag, Au metallic nanoparticles (NPs) can be exploited for biosensing, drug delivery, bioimaging; fluorescence and luminescence of semiconductor CdS, CdSe NPs for immunoassays, bioimaging, biosensing; magnetism of magnetic Fe3O4 for MRI, drug delivery; electronic, mechanical and conductivity of carbon nanotubes (CNTs), and fullerene for drug, gene delivery, therapy and biosensing [9].
Gold nanoparticles, including rods (Figure 2B), enter cells by a non-specific process of endocytosis and concentrate in endosomes [10]. Chithrani
2. Application area
2.1. Role of size and shape of nanomaterials in biomedical applications
The role of proper size and shape of nanomaterials is un-debatable in biomedical applications. Moreover, multifaceted aspects of size and shapes of nanomaterials always remain inspiration to many researchers in this domain. Nevertheless, classification of particles is inevitable in this context.
Particles can be classified according their size, in terms of diameter; coarse particles in a range between 10,000 and 2,500 nm, fine particles, 2,500 and 100 nm and ultrafine particles or nanoparticles 100 and 1 nm [14].
2.2. Nanoparticles selection based on size, shape and surface
Selection of nanoparticles is indispensable step prior its application and it should be based on their earlier reported effects and potential effects with consideration of size, shape and surface.
2.2.1. Size
Size determines the surface to volume ratio, and can strongly affect the material uptake and biodistribution, e.g. drug loaded nanoparticles can be used for site specific drug delivery only when uptake and blood circulation could be feasible. Blood Brain Barrier (BBB) and Blood Retina Barrier (BRB) like problems are still challenging task for site specific drug delivery due to size problem.
2.2.2. Shape
Shape is critical parameter which effects cell uptake and/or the rate and site specific drug delivery from the system. Preferential interaction with specific proteins could be achieved on proper shape selection of nanomaterials.
2.2.3. Surface
Surface and/or functionalized surface of nanomaterial has a special significance, since surface molecules determine the particles hydrophobic or hydrophillic, lipophobic or lipophillic, nature of particles and the extent to which they will interact with other molecules or trigger an immune response [15].
Non linear optical properties of nanostructured materials [16-18] can be useful in optoelectronics. Size and shape dependent properties of noble nanomaterials are resulting in the strong scattering and absorption of light [19-21] due to large optical field enhancement, however in semiconductors, due to the confinement of the electronic motion to a length scale that is comparable to or smaller than the length scale characterizing the electronic motion in bulk semiconducting material [22-24]. In case of noble metals, as the size is reduced to tens of nanometers scale, a new very strong absorption is observed, due to the collective oscillation of the electrons in the conduction band from one surface of the particle to the other.[25, 26].
2.3. Targeted drug delivery by nanoparticles
Targeted drug delivery, is to confine, target and have a protected drug interaction with the diseased tissue. The advantages of the targeted release system are the less number of dosages to the patient, whereas the disadvantage of the high cost may not be affordable by the patient. Cost reduction without affecting drug efficiency against the diseased tissue is prime demand of the society. Due to high surface to volume ratio and less cost as compare to bulk materials, nanoparticles could be the best option in this regard.
2.4. The role of blood vessel
The blood vessels are the part of the circulatory system that transports blood throughout the body. Hence, it is frequently adopted for delivery of the drug for a sustained period of time to target diseased area. Frankly speaking, the drug delivery system requires various disciplines, such as chemists, biologist and engineers, to join forces to optimize this system.[27]. In case of anticancer drug to effective in cancer treatment they should be able to reach the desired tumor with minimal loss of their volume and activity in the blood circulation. Moreover, after reaching the tumor tissue, they should have selectivity in killing tumor cells without affecting normal cells. Here, the number of doses can be reduced with extra benefit of fewer side effects of extra doses of drug in existing methodology. Nanoparticles of appropriate size and shape can be used as effective drug carrier.
2.5. The significance of size, shape and surface characteristics of nanoparticles in biomedical applications
Drug loaded nanoparticles should remain sufficient period in blood stream to interact with an active site of the drug with the tumor. Conventional surface non reformed nanoparticles are usually trapped in the circulation by the reticulo endothelial system, such as the liver and the spleen, reliant on their size and surface characteristics [28]. Hence, size, shape and surface characteristics play significant role in tumor targeted drug delivery.
Lia [29] presented a thermodynamic approach to elucidate the effects of the size and shape of nanoparticles on endocytosis. It was found that endocytosis needs to surmount a thermodynamic energy barrier and has a minimum radius of nanoparticles for endocytosis. Through referring to the concept of “diffusion length of receptors,” he obtained a simple and analytical expression for the optimal size of nanoparticles and suggested that the spherical nanoparticles with the optimal radius about 25 nm have the fastest endocytosis speed. Pan
2.5.1. Significance of size
Small size of nanoparticles are preferred, since after drug loading overall diameter should be more than enough to circulate though out the blood circulatory network for sustained period of time. Ankamwar
2.5.2. Significance of shape
Shape of nanoparticles is also equally important in sustained drug delivery as good as their size. Spherical nanoparticles are good option for drug delivery; however anisotropic structures could be the best option due to their large surface area e.g. dendrimer. This kind of structures can make good seating and binding arrangements for the drug which can be useful for sustained drug delivery. However, sharp edges of anisotropic structures can be responsible for injury of blood vessels [35].
The mechanism that allows nanoparticles to cross the cell membrane has been the subject of much recent research because the understanding and control of such uptake processes is important for the development of nanomedicine [35, 36]. Cellular uptake through endocytosis is crucial for drug delivery and nanomedicine. However, the conditions under which passive endocytosis (i.e. not ATP driven) takes place are not well understood. We report MD simulations of the passive uptake of ligand-coated nanoparticles with varying size, shape, coverage, and membrane-binding strength. They found that the efficiency of passive endocytosis was higher for spherocylindrical particles than for spheres and that endocytosis was suppressed for particles with sharp edges.
2.5.3. Significance of surface characteristics of nanoparticles
In addition to their size and shape, the surface characteristics of nanoparticles are also an indispensable factor determining their life span, fate during circulation, drug binding and site specific release. Nanoparticles should ideally have a hydrophilic surface to escape macrophage capture [37]. This can be achieved in two ways: coating the surface of nanoparticles with a hydrophilic polymer, such as PEG, protects them from plasma proteins; alternatively, nanoparticles can be formed from block copolymers with hydrophilic and hydrophobic domains [38, 39].
However, Elsabahy and Wooley [34] suggested that the surface chemistry of the nanomaterials greatly impact their toxicity, immunogenicity, biodistribution and excess positive charge results in rapid opsonization and clearance with possible blood vessels and capillary occlusion.
2.5.4. Significance of nanoshells
When the nanoshells are used for the drug delivery these shells wrap the tumor cells. When external field of infrared light is applied the tumor cells gets destroyed and the normal cells are left unaffected. Nanoshells tuned to absorb NIR radiation are particularly useful as mediators of photo thermal cancer therapy because they efficiently convert absorbed radiation into heat, and are thermally stable at therapeutic temperatures. The inert gold surface of nanoshells provides several advantages, including biocompatibility, non cytotoxicity, and it also facilitates conjugation to monoclonal antibodies or other biomolecules for both active tumor targeting and biosensing applications.
Nanoshells exhibit unique properties because their interaction with the electromagnetic field is greatly intensified by a phenomenon known as Localized Surface Plasmon Resonance (LSPR). This resonance effect arises from the collective oscillation of the conduction electrons in the gold shell, which efficiently couple to the incident electromagnetic field, and propagate along the surface [40].
2.6. Comparison between nanorods and nanospheres
The use of spherical gold nanoparticles are common practice for drug delivery, however the use of gold nanorods, have the promising feature in this regard. The nanorods of different lengths absorb different frequencies of infrared radiation. It is shown that gold nanorods absorb infrared much more efficiently than spherical gold nanoparticles. Therefore gold nanorods do a better job of absorbing infrared light and heating up the tumor than spherical nanoparticles do [41]. Hence, could be the best option in hyperthermia of tumors. Mere absorption of infrared light to maximum extent does not solve destruction of tumor problem. Magnetic nanoparticles such as spherical and rod shaped Fe3O4 coated with gold could be the better option, since magnetic Fe3O4 nanoparticles can be utilized for site specific drug delivery under the influence of applied external magnetic field and gold coating for hyperthermic destruction of tumors. Obviously, triangular gold nanoprisms would be the best option than rod shaped nanoparticles and rod shaped nanoparticles would be better option than spherical nanoparticles.
2.7. Thermotherapy or hyperthermia of tumors
Hyperthermia is one of the many treatment options that may be used in treating cancer. Hyperthermia therapy is a type of medical treatment in which body tissue is exposed to slightly higher temperatures to damage and kill cancer cells or to make cancer cells more sensitive to the effects of radiation and certain anti-cancer drugs [42, 43]. When combined with radiation therapy, it is called thermoradiotherapy. The preferential killing of cancer cells without damaging normal cells has been a desired goal in cancer therapy for many years. However, the various procedures used to date, including chemotherapy, radiotherapy or surgery, can fall short of this aim [44]. The potential of hyperthermia as a treatment for cancer was first predicted following observations that several types of cancer cells were more sensitive to temperatures in excess of 41°C than their normal counterparts [45, 46]. In the past external means of heat delivery were used such as ultrasonic or microwave treatments, but more recently research has focused on the injection of magnetic fluids directly into the tumour body, or into an artery supplying the tumour. The magnetic fluids used are preferably suspensions of super paramagnetic particles, prepared much as described for MRI contrast agents, as these produce more heat per unit mass than larger particles [47]. The level heating is simply controlled by the materials Marie Curie temperature, that is, the temperature above which materials loses their magnetic properties and thus their ability to heat [48]. There are two approaches, the first is called magnetic hyperthermia and involves the generation of temperatures up to 45–47°C by the particles. This treatment is currently adopted in conjunction with chemotherapy or radiotherapy, as it also renders the cells more sensitive [49]. The second technique is called magnetic thermoblation, and uses temperatures of 43–55°C that have strong cytotoxic effects on both tumour and normal cells [45, 50]. The reason for this use of increased temperatures is due to the fact that about 50% of tumours regress temporarily after hyperthermic treatment with temperatures of up to 44°C, therefore authors prefer to use temperatures up to 55°C [50]. On the basis of recent studies, tumours with volumes of approximately 300mm3 can be heated and no potential problems were expected with larger tissue volumes (e.g.
Various different types of nanocrystallites such as iron nanospheres Figure 4 (A), iron@Au core-shell nanosphere (B), iron@Au core-shell nanorods (C) may be injected intravenously. These nanoparticles are randomly oriented at the point of injection; however under the influence of magnetic field, they can be oriented in proper direction. External magnet can be used for proper orientation and site target delivery of magnetic nanoparticles as shown in Figure 4 alternating magnets generate heat to kill cancer cells. The method relies on the theory that any metallic objects when placed in an alternating magnetic field will have induced currents flowing within them. The amount of current is proportional to the size of the magnetic field and the size of the object [44]. As these currents flow within the metal, the metal resists the flow of current and thereby heats, a process termed inductive heating. If the metal is magnetic, such as iron, the phenomenon is greatly enhanced. Therefore, when a magnetic fluid is exposed to an alternating magnetic field the particles become powerful heat sources, destroying the tumour cells [51, 52] (Figure 5). The proper disposal of dead tumor cells and magnetic particles is also equally important. External magnetic field can be utilized to direct magnetic particles towards excretory organ as shown in Figure 6. Superparamagnetic iron oxide nanoparticles have been used for many years as Magnetic Resonance Imaging (MRI) contrast agents [53], receptor-mediated targeting of magnetic nanoparticles using insulin as a surface ligand to prevent endocytosis. However, gold coated spherical or rod iron nanoparticles can be better option for their scattering properties for imaging and laser therapy both combine together along with magnetic properties of iron nanoparticles. Gold coated iron nanorods could be the best option for thermotherapy in addition to imaging and laser therapy, since gold nanorods absorb infrared radiation better than spherical gold particles.
Tissue and cell-specific drug targeting by superparamagnetic iron oxide nanoparticles can be achieved by employing nanoparticles coatings or carrier-drug conjugates that contain a ligand recognized by a receptor on the target cell. In this study, superparamagnetic iron oxide nanoparticles with specific shape and size have been prepared and coupled to insulin for their targeting to cell expressed surface receptors and thereby preventing the endocytosis [53]. Figure 7 depicts a schematic diagram of cell target drug delivery and hyperthermia of tumors under the influence of alternating magnetic field: iron@drug (A), iron@Au@drug core-shell nanosphere (B), iron@Au@drug core-shell nanorods (C) and cancer cells (D). Figure 8 shows tumor cell death and Figure 9 the proper disposal of dead tumor cells and magnetic particles towards excretory organs. Here magnetic particles are intended to use for tumor specific site delivery under the influence of external magnetic field and hyperthermia of tumors. However, gold coating can be used to loading drug and imaging due to scattering properties of gold nanoshell. Obviously, gold coated nanorods would be best option due to infrared absorption properties of gold nanorods, which in turn can be used for laser therapy. The best combination of various therapies such as chemotherapy by tumor specific drug delivery, thermotherapy (hyperthermia) and laser therapy would be the most suitable option to solve cancer problem to maximum extent as depicted in Figure 7-9. Many oncologists agree with multi therapy rather than any single therapy for cancer treatment. Since in many type of cancer cells single therapy did not show 100% cure.
2.8. Advantages of nanorods over nanospheres
By combining the delivery of rods with drugs, tumor death is triggered with minimizing toxicity by a combination of chemotherapy and external laser beam stimulation. Apart from an initial laser cost, the combination of these two drugs would be relatively noninvasive and inexpensive [54].
We also note that silica nanospheres with a nanoscale overcoat of gold (“nanoshells”) also have tunable absorption in the visible and NIR, and these materials are the subject of another recent review [55].
Size (nm) | |||||
Ankamwar | ~5nm | Sphere | COOH, NH2 | U-251 Glia cancer cells | 75 |
Ankamwar | ~5nm | Sphere | COOH, NH2 | T47D Breast cancer cells | 81 |
Jie Pan | 280–300 nm | Sphere | TPGS-COOH, PEG | MCF-7 breast cancer cells and NIH 3T3 cells | In vitro cell viability of MCF-7 cells treated with free QDs is 80%, QDs-loaded 11.1% (tri-noctylphosphine oxide (TOPO)-capped QDs) TC NPs is 95% and QDs-loaded 11.1% (folate-decorated) FD NPs is 82% at the same 0.63 nMQDs concentration after 4 h and 24 h. In vitro cell viability of NIH 3T3 cells treated with free QDs is 87 %, QDs-loaded 11.1% TC NPs is 90% and QDs-loaded 11.1% FD NPs 89% at the same 0.63 nMQDs concentration after 4 h and 24 h. |
Niidome | 65 nm | Rod | CTAB, PEG | HeLa cells | 80% cell death with 0.05 mMCTAB-coated nanorods, only 10% of cell death at 0.5 mM PEG coated nanorods. |
Takahashi | 65 nm | Rod | Phospatidyl choline | HeLa cells | Phosphatidylcholine modified gold nanorods were much less toxic than C-TAB coated nanorods. |
Sun | --- | --- | --- | Sarcoma 180 mouse tumor cell line (S180) and SGC-7901 human gastric carcinoma cell line (SGC-7901) | The concentration of the gold complexes is 32 μM. Sarcoma 180 mouse tumor cell line S180cell human gastric carcinoma cell line SGC-7901cell. ClAuTCPPNa treated with S180 cell and SGC-7901 cell shows cell viability 66.63% and 57.93% respectively. ClAuTPPCOONa treated with S180 cell and SGC-7901 cell shows cell viability 16.46% and 50.47% respectively. The result showed that the anti-tumor activity of ligandTCPPNa is lower than its gold(III) complex. |
Temminka | --- | --- | --- | WiDr and H630 | The cell viability of WiDr cells treated with TFTc at 2 nM shows 95% after 72 hrs. The cell viability of H630 cells treated with TFTc at 0.5 nM shows 95% after 72 hrs. |
Wei | 10–30 nm | Sphere | MAA-coated nanoparticles | CBRH7919 liver cancer cells | CdS-based QDs was prepared and cellular imaging was conducted. The (QDs) CdS–MAA–PEI–FA has highly photostable and very excellent water-dispersibility and bioimaging. By use of confocal microscopy, demonstrated the internalization of QD–MAA–PEI–FA in FRs (folate receptors) over expressing tumor cells such as CBRH7919livercancer cell and their receptor-mediated uptake is confirmed by the rapid uptake (in less than 3 h). |
Abbasalipourkabir | 145.00±3.39 | Sphere | 30% lecithin and 1 % oleyl alcohol | MCF-7 and MDA-MB231 | Cell viability of MCF-7 MDA-MB231 and cells treated with SLN-03 for 72hr is 45 and 50% respectively. |
Pourgholami | --- | --- | ABZ–CD + citric acid (CA) | human ovarian cystadenocarcinomacancer cell lines 1A9, OVCAR-3 and SKOV-3 | The cell viability of human heptocytes cells treated with ABZCD+CA(albendazoleβ-cyclodextrins + citric acid) at 1 µM shows 90% after 3 days. |
Yong | ---- | Rods | CTAB | Pancreatic cancer cell lines | The cell viability of Panc-1 treated with anti-claudin 4 and drug conjugated QDs with ADM at 1.1 µM shows 66% for 24 h. |
Glazer | ------ | Sphere | PEG | Panc-1 or Cama-1 cells | Cell viability greater than 92% CdSe quantum dot toxicity has been reported at concentrations greater than 0.8 μM. 26 indium based quantum dots InGaPhosphide (i.e., eFluorNC700) are ten times less toxic. |
Das et al. [66] | 8 nm | Sphere | poloxamers,poloxamines or polyethylene glycol (PEG) derivatives | human cervical HeLa cancer cells, | The cell viability of HeLa cells treated with folate conjugated magnetite NPs at 200 µg/ml of magnetite NPs is 97%. No significant reduction in cellular viability was observed, the survival rate being higher than 90%, even at the highest nanoparticle concentration. |
Gupta | 550 nm | --- | Insulin | Infinity telomerase-immortalized primary human fibroblasts (hTERT-BJ1, Clonetech Laboratories, Inc., Hampshire, U.K.) | Insulin-coated nanoparticles revealed no cytotoxic effects to cells, and they remained more than 100% viable relative to control at concentration as high as 1mg/ml. Incubation with uncoated plain magnetic particles, the fibroblasts showed significant loss in viability of about 25%-50% observed at concentrations 250 g/ml. |
Ahrens | ~50 nm | Sphere | Polysaccharide | Bone marrow myeloid progenitor cells from NOD mice ,myeloid progenitor cell | The result demonstrate that RME (receptor-mediated endocytosis) of magnetic nanoparticles effectively labels DCs in vitro, the labeling procedure does not harm the cell’s immunological function and labeled cells can be visualized in vivo in a longitudinal fashion. |
2.9. Biomedical applications of quantum dots
Quantum dots with their extensive excitation spectra, sharp emission spectra, and easily tunable emission properties are hypothetical candidates for replacing conventional fluorescent markers in biodetection assays. Having already shown considerable promise as intracellular imaging and tracking agents [68] quantum dots made of CdSe and ZnS, with few exceptions [69] have not been widely investigated as materials for biodetection assays. The first example of chemically modifying CdSe quantum dots with DNA involved ligand exchange coupled with particle surface engineering [70]. Recent studies employed quantum dots as labels imbedded in polymeric structures [71].
2.10. Electrical detection using nanowire and nanotubes
Nanotubes and nanowires are being reconnoitered as new signal transduction motifs in the electrical detection of DNA as they have for the detection of gases [72], small molecules [73] and proteins. For example, Lieber and colleagues demonstrated that silicon nanowires functionalized with PNA can be used for real-time, label-free detection of DNA at concentrations as low as 10 fM [74].
2.11. Biomedical applications of carbon nanotubes
CNTs have very interesting physicochemical properties, such as ordered structure with high aspect ratio, ultra-light weight, high mechanical strength, high electrical conductivity, high thermal conductivity, metallic or semi-metallic behaviour and high surface area. The combination of these characteristics makes CNTs unique materials with the potential for diverse applications [75, 76]. Cui
2.12. Biomedical application of silver nanoparticles
Silver nanoparticles are being used increasingly in wound dressing, catheters and various household products due to their antimicrobial activity. AshaRani et al. [78] reported that silver nanoparticles are cytotoxic, genotoxic and antiproliferative. As a general rule, the DNA damaging agents have the potential to cause genome instability, which is predisposing factor carcinogenesis. Future applications of Ag nanoparticles as an antiproliferative agent could be limited by the fact that it is equally toxic to normal cells [78]. Nevertheless, Sanpui
2.13. Future prospects
Lot of work on
The majority of commercial nanoparticles applications in medicine are geared towards drug delivery. There are some developments in directing and remotely controlling the functions of nano-probes, for example driving magnetic nanoparticles to the tumour and then making them either to release the drug load or just heating them in order to destroy the surrounding tissue [80]. However, multi-therapy in cancer treatment is advocated by many researchers, which also suggests that experts from various discipline should come together to kill cancer problem before it will be too late. These also suggest that there is no place for compartmentalized treatment to the knowledge in their own box rather tailoring together is and would be the only and lonely solution and need of the time.
3. Conclusion
Size, shape and surface coating of nanomaterials are critical parameter which effects cell uptake and/or the rate and site specific drug delivery from the system. Shapes of nanomaterials are also play important role in infrared absorption, which has special significance in phototherapy. Anisotropic nanoparticles such as rod and triangular shaped gold nanoparticles strongly absorb in visible and NIR region. This special property of gold anisotropic nanoparticles could be exploited in hyperthermia of tumors. For site specific drug delivery magnetic particles such iron oxide could be the best option under the influence of alternating magnetic field. However, mere iron oxide nanoparticles did not prove the best option for cancer therapy. Nevertheless, iron oxide nanoparticles coated by gold shell along with loaded anticancer drug would be the best option for hyperthermia, phototherapy and chemotherapy together. In conclusive remark, I could not resist mentioning, one should not forget that the main reason of any kind of diseases is our life style, which includes our food style, regular sufficient sleep/rest and foremost important key point is our thinking or will power.
References
- 1.
Shiv Shankar. S. Rai A. Ankamwar B. Singh A. Ahmad A. Sastry M. 2004 Biological Synthesis of Triangular Gold Nanoprisms. Nat. Mate.3 482 488 - 2.
Da Costa. K. Dmitriev 2010 Comparative Analysis of Circular and Triangular Gold Nanodisks for Field Enhancement Applications. J. Microw. Optoelectron. Electromagn. Appl. 2: 123-130. - 3.
Ankamwar B. Chaudhary M. Sastry M. 2005 Gold Nanotriangles Biologically Synthesized using Tamarind Leaf Extract and Potential Applications in Vapor Sensing. Syn. React. Inorg. Metal Org. Nano-Metal Chem.35 19 26 - 4.
Ankamwar B. Lai T. Huang J. Liu R. Hsiao M. Chen C. Hwu Y. 2010 Biocompatibility of Fe3O4 Nanoparticles Evaluated by in vitro Cytotoxicity Assays using Normal, Glia and Breast Cancer Cells. Nanotechnology 21: 075102 (9pp). - 5.
Ankamwar B. 2010 Biosynthesis of Gold Nanoparticles (Green-gold) using Leaf Extract of Terminalia catappa. E-J.Chem.7 4 1334 1339 - 6.
Kandil F. Soliman A. Skodack S. Mabry T. 1999 A new Anticancer Tannin and Known Tannins from Terminalia catappa. Asian J. Chem.11 1001 1004 - 7.
Pawar S. Pal S. 2002 Antimicrobial Activity of Extracts of Terminalia catappa Root. Indian J. Med. Sci.56 6 276 278 - 8.
Lin C. Hsu Y. Lin T. 2001 Modifying Effects of Terminalia catappa on Azoxymethane-Induced Colon Carcinogenesis in Male F344 Rats. Anticancer Res.21 237 243 - 9.
Wang X. Liu L. Ramstro° O. Yan M. 2009 Engineering Nanomaterial Surfaces for Biomedical Applications Exp. Biol. Med.234 1128 1139 - 10.
Pissuwani D. Valenzuela S. Cortie M. 2008 Prospects for Gold Nanorod Particles in Diagnostic and Therapeutic Applications. Biotechnol. Genet. Eng. Rev.25 93 112 - 11.
Chithrani B. Ghazani A. Chan W. 2006 Determing the Size and Shape Dependence of Gold Nanoparticle Uptake into Mammalian Cells. Nano Lett.6 662 668 - 12.
Osaki F. Kanamori T. Sando S. Sera T. Aoyama Y. 2004 J. Am. Chem. Soc.126 6250 1 - 13.
Huang X. Jain P. El -Sayed I. El -Sayed M. 2007 Special Focus: Nanoparticles for Cancer Diagnosis and Therapeutics- Review. Nanomedicine2 681 693 - 14.
Granqvist C. Buhrman C. Wyns J. Sievers A. 1976 Far-Infrared Absorption in Ultrafine Al Particles. Phys. Rev. Lett.37 625 629 - 15.
Guidelines for Nanotoxicology Researchers using Nanocomposix Materials February 2012 1 Nanocomposix.com - 16.
Chandra M. Indi S. Das P. 2007 J. Phys. Chem. C. 111: 1065. - 17.
Segets D. Tomalino L. Gradl J. Peukert W. 2009 J. Phys. Chem. C. 113: 11995. - 18. Boyd R. Nonlinear Optics. San Diego, CA: Academic Press; 1992.
- 19.
Griffin J. Singh A. Senapati D. Rhodes P. Mitchell K. Robinson B. Yu E. Ray P. 2009 Size- and Distance-Dependent Nanoparticle Surface-Energy Transfer (NSET) Method for Selective Sensing of Hepatitis C Virus RNA. Chem. Eur. J. 15: 342. - 20.
Liu J. Cao Z. Lu Y. 2009 Functional Nucleic Acid Sensors. Chem. Rev. 109: 1948. - 21.
Li D. Song S. Fan C. 2010 Target-responsive Structures for Nucleic Acid Sensors. Acc. Chem. Res.43 631 641 - 22.
Zhang H. Banfield J. 2009 Identification and Growth Mechanism of ZnS Nanoparticles with Mixed Cubic and Hexagonal Stacking J. Phys. Chem. C.113 9681 9687 - 23.
Rodriguez E. Cid B. Antonio M. Ivanenko V. Lipovskii A. 2009 Chem. Phys. Lett. 467: 335. - 24.
Duboisset I. Russier-Antoine E. Benichou G. Jonin B. Brevet P. 2009 Single Metallic Nanoparticle Sensitivity with Hyper Rayleigh Scattering. J. Phys. Chem. C. 113: 13477. - 25.
Singh A. Senapati D. Wang S. Griffin J. Neely A. Candice P. Naylor K. Varisli B. Kalluri J. Ray P. 2009 Gold Nanorod Based Selective Identification of Escherichia coli Bacteria Using Two-Photon Rayleigh Scattering Spectroscopy. ACS Nano. 3: 1906. - 26.
Ray P. 2010 Size and Shape Dependent Second Order Nonlinear Optical Properties of Nanomaterials and Its Application in Biological and Chemical Sensing. Chem. Rev.110 5332 5365 - 27.
Muller R. Keck C. 2004 Challenges and Solutions for the Delivery of Biotech Drugs- A Review of Drug Nanocrystal Technology and Lipid Nanoparticles. J. Biotech.113 151 170 - 28.
Moghimi S. Hunter A. Murray J. 2001 Long-circulating and Target-specific Nanoparticles: Theory to Practice. Pharmacol. Rev.53 283 318 - 29.
Lia X. 2012 J. Appl. Phys. 111: 024702. - 30.
Pan Y. Neuss S. Leifert A. Fischler M. Wen F. Simon U. Schmid G. Brandau W. Jahnen-Dechent W. 2007 Size-Dependent Cytotoxicity of Gold Nanoparticles. Small3 1941 1949 - 31.
Sun S. Zeng H. Robinson D. Raoux S. Rice P. Wang S. Li G. 2004 J. Am. Chem. Soc.126 273 9 - 32.
Wisse E. Braet F. Luo D. De Zanger R. Jans D. Crabbé E. Vermoesen A. 1999 Structure and Function of Sinusoidal Lining Cells in the Liver. Toxicol. Pathol.24 100 11 - 33.
Yuan F. Dellian M. Fukumura D. Leunig M. Berk D. Torchilin V. Jain R. 1995 Vascular Permeability in a Human Tumor Xenograft: Molecular Size Dependence and Cutoff Size. Cancer Res.55 3752 6 - 34.
Elsabahy M. Wooley K. 2012 Chem. Soc. Rev.41 2545 2561 - 35.
Vacha R. Martinez-Veracoechea F. Frenkel D. 2011 Nano Lett.11 5391 5395 - 36.
Reynwar B. Illya G. Harmandaris V. Muller M. Kremer K. Deserno M. 2007 Nature447 461 4 - 37.
Yang K. Ma Y. 2010 Nat. Nanotechnol.5 579 583 - 38.
Harris J. Martin N. Modi M. 2001 A Novel Process for Modifying Pharmacokinetics. Clin. Pharmacokinet.40 539 51 - 39.
Adams M. Lavasanifar A. Kwon G. 2003 Amphiphilic Block Copolymers for Drug Delivery. J. Pharm. Sci.92 1343 55 - 40.
Chien W. Szkopek T. 2008 Multiple- Multipole Simulation of Optical Near Fields in Discrete Metal Nanospheres Assemblies. OpEx.16 1820 1835 - 41. http://www.understandingnano.com/nanomedicine-nanorod-targeted-drug-delivery.html
- 42.
van der Zee J. 2002 Annals of Oncology13 1173 1184 - 43.
Wust P. Hildebrandt B. Sreenivasa G. et al. 2002 Lancet Oncology.3 8 487 497 - 44.
Berry C. Curtis A. 2003 Funtionalisation of Magnetic Nanoparticles for Applications in Biomedicine. J. Phys. D: Appl. Phys. 36: R198 R206. - 45.
Jordan A. Wust P. Scholz R. Tesche B. Fahling H. Mitrovics T. Vogl T. Cervos-Navarro J. Felix R. 1996 Cellular Uptake of Magnetic Fluid Particles and theirEffects on Human Adenocarcinoma Cells Exposed to AC Magnetic Fields in-vitro. Int. J. Hyperthermia12 705 22 - 46.
Neilsen O. Horsman M. Overgaard J. 2001 E. J. Cancer.37 1587 1589 - 47.
Mitsumori M. Hiraoki M. Shibata T. Okuno Y. Nagata Y. Nishimura Y. Abe M. Hasegawa M. Nagae H. Ebisawa Y. 1996 Targeted Hyperthermia Using Dextran Magnetite Complwe: A New Treatment Modality for Liver Tumors. Hepato-Gastroenterology43 1431 1437 - 48.
Rehman J. Landman J. Tucker R. Bostwick D. Sundaram C. Clayman R. 2002 Ferromagnetic Self-Regulating Reheatable Thermal Rd Implants for in-situ Tssue Ablation. J. Endourol.16 523 531 - 49.
Hilger I. Fruhauf K. Andra W. Hiergeist R. Hergt R. Kaiser W. A. 2002 Acad. Radiol.9 198 202 - 50.
Hilger I. Andra W. Hergt R. Hiergeist R. Schubert H. Kaiser W. A. 2001 Electromagnetic Heating of Breast Tumours in Interventional Radiology: in-vitro and in-vivo Studies in Human Cadavers and Mice. Radiology218 570 575 - 51.
Babinkova M. Leszczynska D. Sourivong P. Babinec P. 2000 Med. Hypoth.54 177 179 - 52.
Babinkova M. Sourivong P. Leszczynska D. Babinec P. 2000 Blood-Specific Whole-Body Electromagnetic Hyperthermia. Med. Hypoth.55 459 460 - 53.
Gupta A. Berry C. Gupta M. Curtis A. 2003 Receptor-Mediated Targeting of Magnetic Nanoparticles Using Insulin as a Surface Ligand to Prevent Endocytosis. IEEE Transactions on NanoBioscience2 255 261 - 54. http://www.ibridgenetwork.org/utah/targeted-combination-drug-delivery-and-photothermal-therapy-f_1
- 55.
Hirsch L. Gobin A. Lowery A. Tam F. Drezek R. Halas N. West J. 2006 Ann. Biomed. Eng.34 15 22 - 56.
Pan J. Fen S. 2009 Targeting and Imaging Cancer Cells by Folate-Decorated Quantum Dots (QDs)- Loaded Nanoparticles of Biodegradable Polymers. Biomaterials30 1176 1183 - 57.
Niidome T. Yamagata M. Okamoto Y. Akiyama Y. Takahashi H. Kawano T. Katayama Y. Niidome Y. 2006 PEG-Modified Gold Nanorods with a Stealth Character for in vivo Applications. J. Control. Release.114 343 347 - 58.
Takahashi H. Niidome Y. Niidome T. Kaneko K. Kawasaki H. Yamada S. 2006 Modification of Gold Nanorods Using Phosphatidylcholine to Reduce Cytotoxicity. Langmuir22 2 5 - 59.
Liang S. Chen H. Zhang Z. Yang Q. Tong H. Xu A. Wang C. 2012 J. Inorg. Biochem.108 47 52 - 60.
Temminka O. Hoebea E. Fukushim M. Peters G. 2007 Irinotecan-Induced Cytotoxicity to Colon Cancer Cells in-vitro is Stimulated by Pre-Incubation with Trifluorothymidine. E. J. Cancer43 175 183 - 61.
Wei G. Yan M. Ma Zhang L. H. 2012 The Synthesis of Highly Water-Dispersible and Targeted CdS Quantum Dots and it is used for Bioimaging by Confocal Microscopy. Spectrochim. Acta Part A85 288 292 - 62.
Abbasalipourkabir R. Abdullah A. 2011 Cytotoxicity Effect of Solid Lipid Nanoparticles on Human Breast Cancer Cell Lines. Biotech.10 528 533 - 63.
Pourgholami M. Wangoo K. Morris D. 2008 Albendazole-Cyclodextrin Complex: Enhanced Cytotoxicity in Ovarian Cancer Cells. Anticancer Research28 2775 2780 - 64.
Yong K. Indrajit Roy. I. Swihart M. Prasad 2009 Multifunctional Nanoparticles as Biocompatible Targeted Probes for Human Cancer Diagnosis and Therapy. J. Mater. Chem. 19: 4655-4672. - 65.
Glazer E. Steven A. Curley S. 2010 Radiofrequency Field-Induced Thermal Cytotoxicity in Cancer Cells Treated with Fluorescent Nanoparicles. Cancer116 3285 3293 - 66.
Das M. Mishra D. Maiti T. Basak A. Pramanik P. 2008 Bio-Functionalization of Magnetite Nanoparticles Using an Aminophosphonic Acid Coupling Agent: New, Ultradispersed, Iron-Oxide FlateNanoconjugates for Cancer-Specific Targeting. Nanotechnology 19: 415101 (14pp). - 67.
Ahrens E. Feili-Hariri M. Xu H. Genoye G. Morel P. 2003 Mag. Reso. Med.49 1006 13 - 68.
Gao X. Cui Y. Levenson R. Chung L. Nie S. 2004 In-vivo Cancer Targeting and Imaging with Semiconductor Quantum Dots. Nat. Biotechnol. 22: 969. - 69.
Gerion D. Chen F. Kannan B. Fu A. Parak W. Chen D. Majumdar A. Alivisatos A. 2003 Anal. Chem. 75: 4766 - 70.
Mitchell G. P. Mirkin C. A. Letsinger R. L. 1999 J. Am. Chem. Soc. 121: 8122. - 71.
Han M. Gao X. Su J. Nie S. 2001 Nat. Biotechnol. 19: 631. - 72.
Patolsky F. Zheng G. Hayden O. Lakadamyali M. Zhuang X. Lieber C. 2004 Electrical Detection of Single Viruses. Proc. Natl. Acad. Sci. 101: 14017. - 73.
Wang J. Musameh M. 2003 Enzyme-Dispersed Carbon-Nanotube Electrodes: A Needle Microsensor for Monitoring Glucose. Analyst 128: 1382. - 74.
Hahm J. Lieber C. 2004 Direct Ultrasensitive Electrical Detection of DNA and DNA Sequence Variations Using Nanowire Nanosensors. Nano Lett. 4: 51. - 75.
Klumpp C. Kostarelos K. Prato M. Bianco A. 2006 Functionalized Carbon Nanotubes as Emerging Nanovectors for the Delivery of Therapeutics. Biochim. Biophys. Acta-Biomembr.1758 404 12 - 76.
Kostarelos K. et al. 2007 Cellular Uptake of Functionalized Carbon nanotubes is Independent of functional Group and Cell Type. Nat. Nanotechnol.2 108 113 - 77.
Cui D. Tian F. Ozkan C. Wang M. Gao H. 2005 Effect ofSingle Wall Carbon Nanotubes on Human HEK293 Cells. Toxicol. Lett.155 73 85 - 78.
Asha Rani. A. Mun G. Hande M. Valiyaveettil S. 2009 Cytotoxicity and Genotoxicity of Silver Nanoparticles in Human Cells. ACS Nano.2 279 290 - 79.
Sanpui P. Chattopadhyay A. Ghosh S. 2011 Induction of Apoptosis in Cancer Cells at Low Silver Nanoparticle Concentrations using Chitosan Nanocarrier ACS Appl. Mater Interfaces.3 218 228 - 80.
Salata O. 2004 Applications of Nanoparticles in Biology and Medicine. J. Nanobiotech.2 1 6